Brain chemical changes detected years before frontotemporal dementia symptoms appear

Researchers tracking families with genetic frontotemporal dementia found measurable neurotransmitter shifts in the prodromal stage—before cognitive decline becomes obvious. The finding could enable earlier intervention and refine how pharma companies design treatments for this aggressive form of dementia.

Originaltitel: Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study